Approval · Notice of Compliance 8042 · 2006
BARACLUDE: Notice of Compliance 8042
Issued June 16, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8042
- Date
- June 16, 2006
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiviral
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BARACLUDE | 02282224 | Marketed |
| BARACLUDE | 02282232 | — |